| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/21/2007 | EP1365787B1 Use of amino acid anticonvulsants for treatment of pain |
| 03/21/2007 | EP1361867B1 Fibrate-statin combinations with reduced fed-fasted effects |
| 03/21/2007 | EP1339735B1 Method for preparing tryptophan rich peptides |
| 03/21/2007 | EP1337629B1 Dipeptidyl peptidases |
| 03/21/2007 | EP1334195B1 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases |
| 03/21/2007 | EP1296663B1 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/21/2007 | EP1289529B1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 03/21/2007 | EP1263460B1 Pharmaceutical carrier composition for papayne based products |
| 03/21/2007 | EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 03/21/2007 | EP1216024B1 Formulation for menopausal women |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1144013B1 Lactone bearing absorbable polymers |
| 03/21/2007 | EP1115381B1 Proteinic drug delivery system using membrane mimetics |
| 03/21/2007 | EP1038025B1 Genetic alterations associated with cancer |
| 03/21/2007 | EP0966532B1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 03/21/2007 | EP0907724B1 Von willebrand factor multimerase |
| 03/21/2007 | EP0865446B1 Agents for promoting bone formation |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | EP0805853B1 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 03/21/2007 | EP0574461B9 High affinity humanized monoclonal antibodies |
| 03/21/2007 | CN2880085Y Collagen protein sponge of packed |
| 03/21/2007 | CN1934255A Combination therapy for the treatment of ocular neovascular disorders |
| 03/21/2007 | CN1934252A Thrombin derivatives and medicinal composition containing the same |
| 03/21/2007 | CN1934123A Intracellular delivery of osteoinductive proteins and peptides |
| 03/21/2007 | CN1933859A Bone graft and scaffolding materials immobilized with osteogenesis enhancing peptides on the surface |
| 03/21/2007 | CN1933855A Method of treatment of a metabolic disease using intranasal administration of exendin peptide |
| 03/21/2007 | CN1933851A Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 03/21/2007 | CN1933850A Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| 03/21/2007 | CN1933849A Methods for treating pain and for treating a medication overuse disorder |
| 03/21/2007 | CN1933848A Y2 selective receptor agonists for therapeutic interventions |
| 03/21/2007 | CN1933847A SMAC peptidomimetics and the uses thereof |
| 03/21/2007 | CN1933824A Coenzyme q compositions persisting in blood |
| 03/21/2007 | CN1932017A Tumor adoptosis inducing ligandin and its application in preparing antitumor medicine |
| 03/21/2007 | CN1932016A Polynucleotide affecting SRE activity and its coding polypeptides and use |
| 03/21/2007 | CN1931875A High purity ulinastatin and its prepn process and medicine composition |
| 03/21/2007 | CN1931874A Prepn process, medicine prepn and medicinal use of ginseng glycopeptide |
| 03/21/2007 | CN1931872A Casein hydrolysate and its prepn process |
| 03/21/2007 | CN1931367A Application of alginate in preparing medicine smell masking prepn |
| 03/21/2007 | CN1931362A Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction |
| 03/21/2007 | CN1931361A Prepn process of blood-nourishing and iron-replenishing health nutrient |
| 03/21/2007 | CN1931360A Double timephase neo-insulin zinc injection (30%) and its prepn process |
| 03/21/2007 | CN1931359A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931358A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931357A Fragrant liquid quitting smoking |
| 03/21/2007 | CN1306036C Method for preparing interferon of white blood cells of dogs |
| 03/21/2007 | CN1306031C Novel natural antibacterial peptide Hippocampusin and its preparation and application |
| 03/21/2007 | CN1305931C Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 03/21/2007 | CN1305898C Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 03/21/2007 | CN1305897C New peptide compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/21/2007 | CN1305896C Protein purification by ion exchange chromatography |
| 03/21/2007 | CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 03/21/2007 | CN1305528C Immunoadjuvant |
| 03/21/2007 | CN1305523C Spirit relieving drink and its preparation method |
| 03/21/2007 | CN1305522C Rat acarpous medicine and its preparation method |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CN1305462C Diffusional implantable delivery system |
| 03/21/2007 | CN1305384C Cheese capable of disinfecting helicobacter pylori |
| 03/20/2007 | US7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 03/20/2007 | US7193073 Aggrecanase |
| 03/20/2007 | US7193072 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of bacterial infections in swine |
| 03/20/2007 | US7193066 Proteolytically treated holotoxin of clostridial neurotoxin is purified by immunoaffinity chromatography or matched ion polynucleotide chromatography |
| 03/20/2007 | US7193063 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma |
| 03/20/2007 | US7193058 Monoclonal antibody which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/20/2007 | US7193056 Process for purifying a compound |
| 03/20/2007 | US7193053 Hypoxia-inducible factor 1alpha variants and methods of use |
| 03/20/2007 | US7193048 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/20/2007 | US7193045 Nucleotide sequences coding polypeptide for use in diagnostics biosensors and thrombolytic agents |
| 03/20/2007 | US7193040 Apoptosis of rectum and prostate cancer |
| 03/20/2007 | US7193039 Comprises tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid; solid phase synthesis; for immunoassay; electron spin resonance/fluorescence; improved enzyme resistance |
| 03/20/2007 | US7193038 Nontoxic, stable polypeptide used as cellular adhesion molecules, wound healing agents, cosmetics,and cell culture substrates |
| 03/20/2007 | US7193037 Biomimetic infrared sensor containing a temperature-sensing helical coiled-coil protein, TlpA8, incorporated into an electroconductive film or gel; lightweight, high sensitivity and excellent dynamic range |
| 03/20/2007 | US7193035 Asparagine in position B3 and lysine in position B29 are replaced by lysine and glutamic acid, respectively; inhalant and oral dosage forms; dissolving and purifying the amorphous powder; antidiabetic agents |
| 03/20/2007 | US7193034 Synthetic peptides, conjugation reagents and methods |
| 03/20/2007 | US7193033 Peptide having appetite stimulating activity |
| 03/20/2007 | US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 03/20/2007 | US7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192931 Treatment of demyelinating diseases |
| 03/20/2007 | US7192930 Method and peptide for regulating cellular activity |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192928 T cell antigen receptor peptides |
| 03/20/2007 | US7192927 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 03/20/2007 | US7192926 Synthetic blood has a high-molecular weight proteins, containing a low hydroxyproline content for preventing from gelling; prevent anaphylactic shock; genetic engineering; replacement of glutamine by glutamic acid and/or replacement of asparagine by aspartic acid |
| 03/20/2007 | US7192925 Genetic engineered venoms is a polypeptide, free of cysteine residues and internal disulfide bridges; enzyme resistance to proteinases; treatment of hypertension |
| 03/20/2007 | US7192924 Corticotropin releasing factor 2 receptor agonists |
| 03/20/2007 | US7192923 For therapy and prophylaxis of muscular dystrophy |
| 03/20/2007 | US7192922 Method of treating left ventricular dysfunction |
| 03/20/2007 | US7192921 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 03/20/2007 | US7192920 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 03/20/2007 | US7192919 Insoluble, amorphous complex comprising insulin and zinc, is in aerosolized form for treating diabetes; administering to the lung through inhalation; a salt formation of insulin and zinc chloride; new chemical derivative of existing drug |
| 03/20/2007 | US7192918 Tripeptide and tetrapeptide sulfones |
| 03/20/2007 | US7192917 treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising administering an antagonist to high mobility group 1 protein |
| 03/20/2007 | US7192915 Methods for treating multiple sclerosis with GGF-related polypeptides |
| 03/20/2007 | US7192914 Administering a dose of an enzyme inhibitor of ST3Gal-IV sialyltransferase; reducing side effect of active drug anticancer drug, a corticosteroid, raloxifene, and a birth control agent |
| 03/20/2007 | US7192754 Nomuraeae rileyi-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/20/2007 | US7192735 Phosphopantetheinyl transferases and uses thereof |
| 03/20/2007 | US7192732 contacting proteins with test compounds, then analyzing binding between the protein and the test compound; screening for drugs which can be used to treat allergic disease, asthma, cancer and neurodegenerative diseases |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |